Improving ophthalmic screening for hydroxychloroquine associated retinopathy
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Ophthalmology"
DOI: 10.1080/17469899.2021.1851599
Abstract: ABSTRACT Background: Hydroxychloroquine is a safe and effective treatment for autoimmune disease. It can however result in a blinding retinopathy the prevalence of which may be 7.5% after five years. Ophthalmology departments must screen for… read more here.
Keywords: screening hydroxychloroquine; hydroxychloroquine; ophthalmology; associated retinopathy ... See more keywords